Vyome Holdings, Inc. (HIND) News
Track canonical SquawkNews coverage tagged to HIND, Vyome Holdings, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 5 indexed stories across 4 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Harvest ETFs announces September 2026 Distributions
Harvest Portfolios Group Inc. (“Harvest”) announces the following monthly distributions for Harvest ETFs in the following table for the month ending September 30, 2026. The distributions will be paid on or about October
NEWS | Sep 23, 2026, 11:30 AM UTC
L
HIND price target set at $3.50 by Chardan Capital
Chardan Capital announced a $3.50 per-share price target for Vyome Holdings (HIND).
EQUITY | Sep 03, 2026, 12:05 PM UTC
L
Vyome appoints Jerry Leonard as CFO; SEC filing dated Aug 27, 2026
Vyome appointed Jerry Leonard as CFO, disclosed in an SEC filing dated August 27, 2026.
REGULATION | Aug 28, 2026, 08:50 PM UTC
L
Vyome appoints Jerry Leonard as CFO; Robert Dickey resigns
Vyome appointed Jerry Leonard as CFO. Robert Dickey resigned from the role.
EQUITY | Aug 28, 2026, 08:34 PM UTC
L
China National Intellectual Property Administration Grants Vyome Patent Chinese Patent No. ZL 2021 1 0758695.X
Newly granted Chinese patent broadens Vyome's intellectual property estate with additional formulation and therapeutic use claims for besifloxacin gel in inflammatory acne, supporting future partnering, licensing and reg
GEOPOLITICS | Jul 01, 2026, 12:07 PM UTC